“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart
Article: ADAMTS13 containing the naturally occurring mutation p.Arg1177Gln adopts an open conformation
Reviews
There are no reviews yet.